Merck KGaA (ETR:MRK) Stock Price Down 0.5% – What’s Next?

Merck KGaA (ETR:MRKGet Free Report)’s stock price fell 0.5% during mid-day trading on Thursday . The company traded as low as €138.45 and last traded at €138.65. Approximately 112,448 shares traded hands during trading, The stock had previously closed at €139.35.

Merck KGaA Price Performance

The company’s fifty day moving average price is €140.57 and its 200 day moving average price is €126.75. The company has a market capitalization of $62.46 billion, a P/E ratio of 23.04, a PEG ratio of 2.37 and a beta of 0.81. The company has a quick ratio of 0.72, a current ratio of 1.69 and a debt-to-equity ratio of 40.77.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.

Featured Articles

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.